[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355148-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355148-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-fatty-acids-in-liver-cancer-molecular-insights-and-drug-approaches","Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches","","Primary liver cancer (PLC), including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is an aggressive malignancy with poor prognosis. Dysregulated fatty acid metabolism is central to HCC progression and therapeutic resistance. This review explains how fatty-acid transport, de novo lipogenesis, and fatty acid oxidation reshape oncogenic signaling, support nutrient-deprived growth, and influence immune function and angiogenesis. It surveys druggable targets, ongoing clinical trials, and challenges for precision integration with current therapies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-fatty-acids-in-liver-cancer-molecular-insights-and-drug-approaches/355148/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-fatty-acids-in-liver-cancer-molecular-insights-and-drug-approaches/355148.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is fatty acid metabolism important in primary liver cancer progression?","Question",{"text":63,"@type":64},"Recent studies show that altered fatty acid metabolism drives survival, proliferation, and drug resistance in PLC cells by triggering oncogenic signaling and helping adaptation to nutrient-deprived conditions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which fatty-acid-related processes are highlighted for HCC progression and therapy resistance?",{"text":68,"@type":64},"The review emphasizes increased fatty acid transporter expression, reprogramming of de novo lipogenesis, and altered fatty acid oxidation as key contributors.",{"name":70,"@type":61,"acceptedAnswer":71},"How does fatty acid metabolism affect the tumor microenvironment in PLC?",{"text":72,"@type":64},"Fatty acid metabolism modulates immune cell function and angiogenesis, thereby shaping the tumor microenvironment and promoting PLC progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355148,1790153122,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nTargeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches  \nAntonio Cigliano 1, *, Dora Pischedda 2, Claudio Pandino 3, Grazia Galleri 3 and Diego F. Calvisi 2, *  \nAcademic Editor: Kiyoshi Ohtani  \nReceived: 2 January 2026  \nRevised: 16 February 2026  \nAccepted: 19 February 2026  \nPublished: 20 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Faculty of Medicine, Saint Camillus International University of Health Sciences, 00131 Rome, Italy  \n2 Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy; [d.pischedda@studenti.uniss.it](d.pischedda@studenti.uniss.it)  \n3 Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy; [claudio.pandino96@gmail.com](claudio.pandino96@gmail.com) (C.P.); [galleri@uniss.it](galleri@uniss.it) (G.G.)  \n* Correspondence: [antonio.cigliano@unicamillus.org](antonio.cigliano@unicamillus.org) (A.C.); [calvisid@uniss.it](calvisid@uniss.it) (D.F.C.); Tel.: +39-079-228306 (D.F.C.)  \nAbstract  \nPrimary liver cancer (PLC), commonly classified as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is a highly aggressive malignancy with a dismal prognosis. Recent research has highlighted the crucial role of dysregulation of fatty acid metabolism in HCC progression and therapeutic resistance. Here, with a focus primarily on HCC, we review how alterations in the processes involving fatty acids dynamically contribute to the survival, proliferation, and development of the drug resistance of PLC cells. In particular, increased expression of fatty acid transporters, reprogramming of de novo lipogenesis, and altered fatty acid oxidation trigger the upregulation of oncogenic signaling pathways and adaptation to nutrient-deprived conditions inducing the rapid proliferation of PLC cells. Furthermore, fatty acid metabolism influences immune cell function and angiogenesis, thereby shaping the tumor microenvironment and promoting the progression of PLC. This review explores the complex relationship between fatty acid metabolism and the progression of PLC. It discusses future directions regarding the most promising druggable targets and their current status in clinical trials. Furthermore, it examines the advancement of innovative therapeutic strategies and highlights the significant challenges in targeting fatty acid metabolism. Finally, it discusses how precision therapies focused on fatty acid metabolism can be effectively integrated with current treatments.  \nKeywords: primary liver cancer; lipid metabolism; metabolic reprogramming; tumor microenvironment; drug resistance; personalized medicine; innovative therapies  \n1. Introduction  \nPrimary liver cancer (PLC) ranks as the third (second in males) most common cause of cancer-related death worldwide, with approximately 900,000 people being diagnosed each year and its incidence steadily increasing [1] . The Global Cancer Observatory (GCO)([https://gco.iarc.who.int](https://gco.iarc.who.int accessed on 18 December 2025)[ accessed on 18 December 2025](https://gco.iarc.who.int accessed on 18 December 2025)) estimates that, by 2045, about 1.5 million people will be affected by PLC, posing a serious health problem partly due to a constant increase in the incidence of metabolic risk factors, including, among others, excess body weight, diabetes, and alcohol consumption [1] . PLCs include mostly hepatocellular carcinoma (HCC), accounting for up to 90% of all cases, and intrahepatic cholangiocarcinoma (ICC), accounting for the remaining 10–15%[2,3] . Chronic HBV and HCV infections are among the most common risk factors in PLC development. However, the frequency of  \nthese infections has decreased in recent years due to the development of effective antiviral drugs and the implementation of successfu","cbCaiqpUy3HnfzwR","https://ap.wps.com/l/cbCaiqpUy3HnfzwR","pdf",2190361,34,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Primary liver cancer burden and risk factors\n## Fatty-acid metabolism as a cancer hallmark\n## Metabolic reprogramming and therapeutic implications","[{\"question\":\"Why is fatty acid metabolism important in primary liver cancer progression?\",\"answer\":\"Recent studies show that altered fatty acid metabolism drives survival, proliferation, and drug resistance in PLC cells by triggering oncogenic signaling and helping adaptation to nutrient-deprived conditions.\"},{\"question\":\"Which fatty-acid-related processes are highlighted for HCC progression and therapy resistance?\",\"answer\":\"The review emphasizes increased fatty acid transporter expression, reprogramming of de novo lipogenesis, and altered fatty acid oxidation as key contributors.\"},{\"question\":\"How does fatty acid metabolism affect the tumor microenvironment in PLC?\",\"answer\":\"Fatty acid metabolism modulates immune cell function and angiogenesis, thereby shaping the tumor microenvironment and promoting PLC progression.\"}]","Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches | PDF",1790116348,86,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da07044d8edea31765c7aa9ede283e40.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2de7e0567991b3bb1fb9ba05b27b8ac.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a556d7e7bd02c020d1bde8ceff1f60d.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb93ff7b29734645007e79a3d7683843.webp",980,1385]